[1]
Yusen RD, Edwards LB, Kucheryavaya AY, Benden C, Dipchand AI, Dobbels F, Goldfarb SB, Levvey BJ, Lund LH, Meiser B, Stehlik J, International Society for Heart and Lung Transplantation. The registry of the International Society for Heart and Lung Transplantation: thirty-first adult lung and heart-lung transplant report--2014; focus theme: retransplantation. The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation. 2014 Oct:33(10):1009-24. doi: 10.1016/j.healun.2014.08.004. Epub 2014 Aug 14
[PubMed PMID: 25242125]
[2]
Verleden GM, Raghu G, Meyer KC, Glanville AR, Corris P. A new classification system for chronic lung allograft dysfunction. The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation. 2014 Feb:33(2):127-33. doi: 10.1016/j.healun.2013.10.022. Epub 2013 Oct 24
[PubMed PMID: 24374027]
[3]
Yousem SA, Zeevi A. The histopathology of lung allograft dysfunction associated with the development of donor-specific HLA alloantibodies. The American journal of surgical pathology. 2012 Jul:36(7):987-92. doi: 10.1097/PAS.0b013e31825197ae. Epub
[PubMed PMID: 22510758]
[4]
Masson E,Stern M,Chabod J,Thévenin C,Gonin F,Rebibou JM,Tiberghien P, Hyperacute rejection after lung transplantation caused by undetected low-titer anti-HLA antibodies. The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation. 2007 Jun;
[PubMed PMID: 17543791]
[5]
Martinu T, Chen DF, Palmer SM. Acute rejection and humoral sensitization in lung transplant recipients. Proceedings of the American Thoracic Society. 2009 Jan 15:6(1):54-65. doi: 10.1513/pats.200808-080GO. Epub
[PubMed PMID: 19131531]
[6]
Estenne M, Maurer JR, Boehler A, Egan JJ, Frost A, Hertz M, Mallory GB, Snell GI, Yousem S. Bronchiolitis obliterans syndrome 2001: an update of the diagnostic criteria. The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation. 2002 Mar:21(3):297-310
[PubMed PMID: 11897517]
[7]
Witt CA, Gaut JP, Yusen RD, Byers DE, Iuppa JA, Bennett Bain K, Alexander Patterson G, Mohanakumar T, Trulock EP, Hachem RR. Acute antibody-mediated rejection after lung transplantation. The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation. 2013 Oct:32(10):1034-40. doi: 10.1016/j.healun.2013.07.004. Epub 2013 Aug 13
[PubMed PMID: 23953920]
[8]
Daoud AH,Betensley AD, Diagnosis and treatment of antibody mediated rejection in lung transplantation: a retrospective case series. Transplant immunology. 2013 Jan;
[PubMed PMID: 23220148]
Level 2 (mid-level) evidence
[9]
Bosanquet JP, Witt CA, Bemiss BC, Byers DE, Yusen RD, Patterson AG, Kreisel D, Mohanakumar T, Trulock EP, Hachem RR. The impact of pre-transplant allosensitization on outcomes after lung transplantation. The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation. 2015 Nov:34(11):1415-22. doi: 10.1016/j.healun.2015.06.003. Epub 2015 Jun 10
[PubMed PMID: 26169666]
[10]
Yusen RD, Edwards LB, Kucheryavaya AY, Benden C, Dipchand AI, Goldfarb SB, Levvey BJ, Lund LH, Meiser B, Rossano JW, Stehlik J. The Registry of the International Society for Heart and Lung Transplantation: Thirty-second Official Adult Lung and Heart-Lung Transplantation Report--2015; Focus Theme: Early Graft Failure. The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation. 2015 Oct:34(10):1264-77. doi: 10.1016/j.healun.2015.08.014. Epub 2015 Sep 3
[PubMed PMID: 26454740]
[11]
Chambers DC, Cherikh WS, Goldfarb SB, Hayes D Jr, Kucheryavaya AY, Toll AE, Khush KK, Levvey BJ, Meiser B, Rossano JW, Stehlik J, International Society for Heart and Lung Transplantation. The International Thoracic Organ Transplant Registry of the International Society for Heart and Lung Transplantation: Thirty-fifth adult lung and heart-lung transplant report-2018; Focus theme: Multiorgan Transplantation. The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation. 2018 Oct:37(10):1169-1183. doi: 10.1016/j.healun.2018.07.020. Epub 2018 Aug 11
[PubMed PMID: 30293613]
[12]
Frost AE, Jammal CT, Cagle PT. Hyperacute rejection following lung transplantation. Chest. 1996 Aug:110(2):559-62
[PubMed PMID: 8697867]
[13]
Bittner HB, Dunitz J, Hertz M, Bolman MR 3rd, Park SJ. Hyperacute rejection in single lung transplantation--case report of successful management by means of plasmapheresis and antithymocyte globulin treatment. Transplantation. 2001 Mar 15:71(5):649-51
[PubMed PMID: 11292295]
Level 3 (low-level) evidence
[14]
Burton CM, Iversen M, Scheike T, Carlsen J, Andersen CB. Minimal acute cellular rejection remains prevalent up to 2 years after lung transplantation: a retrospective analysis of 2697 transbronchial biopsies. Transplantation. 2008 Feb 27:85(4):547-53. doi: 10.1097/TP.0b013e3181641df9. Epub
[PubMed PMID: 18347533]
Level 2 (mid-level) evidence
[15]
De Vito Dabbs A,Hoffman LA,Iacono AT,Zullo TG,McCurry KR,Dauber JH, Are symptom reports useful for differentiating between acute rejection and pulmonary infection after lung transplantation? Heart
[PubMed PMID: 15597291]
[16]
Boehler A, Estenne M. Post-transplant bronchiolitis obliterans. The European respiratory journal. 2003 Dec:22(6):1007-18
[PubMed PMID: 14680094]
[17]
Hayes D Jr. A review of bronchiolitis obliterans syndrome and therapeutic strategies. Journal of cardiothoracic surgery. 2011 Jul 18:6():92. doi: 10.1186/1749-8090-6-92. Epub 2011 Jul 18
[PubMed PMID: 21767391]
[18]
Stewart S, Fishbein MC, Snell GI, Berry GJ, Boehler A, Burke MM, Glanville A, Gould FK, Magro C, Marboe CC, McNeil KD, Reed EF, Reinsmoen NL, Scott JP, Studer SM, Tazelaar HD, Wallwork JL, Westall G, Zamora MR, Zeevi A, Yousem SA. Revision of the 1996 working formulation for the standardization of nomenclature in the diagnosis of lung rejection. The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation. 2007 Dec:26(12):1229-42
[PubMed PMID: 18096473]
[19]
Millet B, Higenbottam TW, Flower CD, Stewart S, Wallwork J. The radiographic appearances of infection and acute rejection of the lung after heart-lung transplantation. The American review of respiratory disease. 1989 Jul:140(1):62-7
[PubMed PMID: 2502057]
[20]
Verleden SE, Vasilescu DM, Willems S, Ruttens D, Vos R, Vandermeulen E, Hostens J, McDonough JE, Verbeken EK, Verschakelen J, Van Raemdonck DE, Rondelet B, Knoop C, Decramer M, Cooper J, Hogg JC, Verleden GM, Vanaudenaerde BM. The site and nature of airway obstruction after lung transplantation. American journal of respiratory and critical care medicine. 2014 Feb 1:189(3):292-300. doi: 10.1164/rccm.201310-1894OC. Epub
[PubMed PMID: 24354907]
[21]
Federica M, Nadia S, Monica M, Alessandro C, Tiberio O, Francesco B, Mario V, Maria FA. Clinical and immunological evaluation of 12-month azithromycin therapy in chronic lung allograft rejection. Clinical transplantation. 2011 Jul-Aug:25(4):E381-9. doi: 10.1111/j.1399-0012.2011.01435.x. Epub 2011 Mar 21
[PubMed PMID: 21418327]
[22]
Vanaudenaerde BM, Meyts I, Vos R, Geudens N, De Wever W, Verbeken EK, Van Raemdonck DE, Dupont LJ, Verleden GM. A dichotomy in bronchiolitis obliterans syndrome after lung transplantation revealed by azithromycin therapy. The European respiratory journal. 2008 Oct:32(4):832-43. doi: 10.1183/09031936.00134307. Epub
[PubMed PMID: 18827151]
[23]
Knoop C,Haverich A,Fischer S, Immunosuppressive therapy after human lung transplantation. The European respiratory journal. 2004 Jan
[PubMed PMID: 14738248]
[24]
Trulock EP, Christie JD, Edwards LB, Boucek MM, Aurora P, Taylor DO, Dobbels F, Rahmel AO, Keck BM, Hertz MI. Registry of the International Society for Heart and Lung Transplantation: twenty-fourth official adult lung and heart-lung transplantation report-2007. The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation. 2007 Aug:26(8):782-95
[PubMed PMID: 17692782]
[25]
Hachem RR, Yusen RD, Meyers BF, Aloush AA, Mohanakumar T, Patterson GA, Trulock EP. Anti-human leukocyte antigen antibodies and preemptive antibody-directed therapy after lung transplantation. The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation. 2010 Sep:29(9):973-80. doi: 10.1016/j.healun.2010.05.006. Epub 2010 Jun 16
[PubMed PMID: 20558084]
[26]
Ensor CR, Yousem SA, Marrari M, Morrell MR, Mangiola M, Pilewski JM, D'Cunha J, Wisniewski SR, Venkataramanan R, Zeevi A, McDyer JF. Proteasome Inhibitor Carfilzomib-Based Therapy for Antibody-Mediated Rejection of the Pulmonary Allograft: Use and Short-Term Findings. American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons. 2017 May:17(5):1380-1388. doi: 10.1111/ajt.14222. Epub 2017 Mar 9
[PubMed PMID: 28173620]
[27]
Levine SM, A survey of clinical practice of lung transplantation in North America. Chest. 2004 Apr;
[PubMed PMID: 15078729]
Level 3 (low-level) evidence
[28]
Martinu T, Pavlisko EN, Chen DF, Palmer SM. Acute allograft rejection: cellular and humoral processes. Clinics in chest medicine. 2011 Jun:32(2):295-310. doi: 10.1016/j.ccm.2011.02.008. Epub 2011 Mar 25
[PubMed PMID: 21511091]
[29]
Fishman JA. Infection in solid-organ transplant recipients. The New England journal of medicine. 2007 Dec 20:357(25):2601-14
[PubMed PMID: 18094380]
[30]
Fuehner T, Simon A, Dierich M, Dewall C, Laenger F, Pletz MW, Welte T, Gottlieb J. Indicators for steroid response in biopsy proven acute graft rejection after lung transplantation. Respiratory medicine. 2009 Aug:103(8):1114-21. doi: 10.1016/j.rmed.2009.03.013. Epub 2009 Apr 26
[PubMed PMID: 19398195]
[31]
Guilinger RA, Paradis IL, Dauber JH, Yousem SA, Williams PA, Keenan RJ, Griffith BP. The importance of bronchoscopy with transbronchial biopsy and bronchoalveolar lavage in the management of lung transplant recipients. American journal of respiratory and critical care medicine. 1995 Dec:152(6 Pt 1):2037-43
[PubMed PMID: 8520773]
[32]
Sarahrudi K, Estenne M, Corris P, Niedermayer J, Knoop C, Glanville A, Chaparro C, Verleden G, Gerbase MW, Venuta F, Böttcher H, Aubert JD, Levvey B, Reichenspurner H, Auterith A, Klepetko W. International experience with conversion from cyclosporine to tacrolimus for acute and chronic lung allograft rejection. The Journal of thoracic and cardiovascular surgery. 2004 Apr:127(4):1126-32
[PubMed PMID: 15052212]
[33]
Meiser BM,Uberfuhr P,Fuchs A,Schulze C,Nollert G,Mair H,Martin S,Pfeiffer M,Reichenspurner H,Kreuzer E,Reichart B, Tacrolimus: a superior agent to OKT3 for treating cases of persistent rejection after intrathoracic transplantation. The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation. 1997 Aug;
[PubMed PMID: 9286771]
Level 3 (low-level) evidence
[34]
Ensor CR, Rihtarchik LC, Morrell MR, Hayanga JW, Lichvar AB, Pilewski JM, Wisniewski S, Johnson BA, D'Cunha J, Zeevi A, McDyer JF. Rescue alemtuzumab for refractory acute cellular rejection and bronchiolitis obliterans syndrome after lung transplantation. Clinical transplantation. 2017 Apr:31(4):. doi: 10.1111/ctr.12899. Epub 2017 Feb 22
[PubMed PMID: 28008661]
[35]
Reams BD, Musselwhite LW, Zaas DW, Steele MP, Garantziotis S, Eu PC, Snyder LD, Curl J, Lin SS, Davis RD, Palmer SM. Alemtuzumab in the treatment of refractory acute rejection and bronchiolitis obliterans syndrome after human lung transplantation. American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons. 2007 Dec:7(12):2802-8
[PubMed PMID: 17924993]
[36]
Meyer KC, Raghu G, Verleden GM, Corris PA, Aurora P, Wilson KC, Brozek J, Glanville AR, ISHLT/ATS/ERS BOS Task Force Committee, ISHLT/ATS/ERS BOS Task Force Committee. An international ISHLT/ATS/ERS clinical practice guideline: diagnosis and management of bronchiolitis obliterans syndrome. The European respiratory journal. 2014 Dec:44(6):1479-503. doi: 10.1183/09031936.00107514. Epub 2014 Oct 30
[PubMed PMID: 25359357]
Level 1 (high-level) evidence
[37]
Cairn J,Yek T,Banner NR,Khaghani A,Hodson ME,Yacoub M, Time-related changes in pulmonary function after conversion to tacrolimus in bronchiolitis obliterans syndrome. The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation. 2003 Jan;
[PubMed PMID: 12531413]
[38]
Whyte RI, Rossi SJ, Mulligan MS, Florn R, Baker L, Gupta S, Martinez FJ, Lynch JP 3rd. Mycophenolate mofetil for obliterative bronchiolitis syndrome after lung transplantation. The Annals of thoracic surgery. 1997 Oct:64(4):945-8
[PubMed PMID: 9354506]
[39]
Burton CM, Carlsen J, Mortensen J, Andersen CB, Milman N, Iversen M. Long-term survival after lung transplantation depends on development and severity of bronchiolitis obliterans syndrome. The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation. 2007 Jul:26(7):681-6
[PubMed PMID: 17613397]
[40]
Heng D, Sharples LD, McNeil K, Stewart S, Wreghitt T, Wallwork J. Bronchiolitis obliterans syndrome: incidence, natural history, prognosis, and risk factors. The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation. 1998 Dec:17(12):1255-63
[PubMed PMID: 9883768]
[41]
Sundaresan S,Trulock EP,Mohanakumar T,Cooper JD,Patterson GA, Prevalence and outcome of bronchiolitis obliterans syndrome after lung transplantation. Washington University Lung Transplant Group. The Annals of thoracic surgery. 1995 Nov;
[PubMed PMID: 8526624]